Walleye Capital’s SQZ Biotechnologies Company SQZ Stock Holding History

Walleye Capital’s Portfolio SQZ Stock Details SQZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-66,008	Closed	-$903	–	1571
2021 Q1	$903	Buy	+66,008	New	+$1.34M	0.05%	334

Other funds holding SQZ

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Walleye Capital's SQZ Position: Q2 2021 in Review

Walleye Capital sold out of SQZ Biotechnologies Company (SQZ) in Q2 2021, closing a stake of 66,008 shares — an estimated $903 sold.

Walleye Capital first reported a position in SQZ in Q1 2021 and held it in 1 quarter. The position peaked at $903 in Q1 2021. 49 funds tracked by Wall St. Rank hold SQZ as of Q2 2021.

Walleye Capital reported no remaining SQZ Biotechnologies Company position as of Q2 2021 after selling out during the quarter.
Walleye Capital sold 66,008 SQZ Biotechnologies Company shares in Q2 2021, an estimated $903.
Walleye Capital first reported a position in SQZ Biotechnologies Company in Q1 2021 and held it in 1 quarter.
Walleye Capital's SQZ Biotechnologies Company position peaked at $903 in Q1 2021.
49 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q2 2021.

Based on Walleye Capital's 13F filing for Q2 2021, filed 16 Aug 2021.